Express News | Dogwood Therapeutics Shares Are Trading Lower. The Company Announced Top Line Data From the Recently Completed BHC IMC-2 Long-COVID Study

BenzingaNov 18 12:14 ET

Dogwood Therapeutics Reports Positive Results From IMC-2 Study on Long-COVID Related Fatigue and Sleep Disturbance

Quiver QuantitativeNov 18 08:50 ET

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

GlobeNewswireNov 18 08:45 ET

Express News | Dogwood Therapeutics, Inc. Announces Low Dose Imc-2 Treatment Reduces Long-Covid Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

ReutersNov 18 08:45 ET

12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaNov 11 16:09 ET

Top Premarket Decliners

MT NewswiresNov 11 07:49 ET